Comments
Brinton Pharmaceuticals on Thursday said it will launch its generic version of anti-Covid pill Molnupiravir next week in India.
The company will introduce it in the domestic market under the brand ‘Molviton’, Brinton Pharmaceuticals said in a statement.
“Our brand Molviton would be available at all leading pharmacies and Covid treatment centres across the country by next week,” Brinton Pharmaceuticals Chairman and Managing Director Rahulkumar Darda said.
Also see: India’s Covid cases more than 10,000 for second day in a row
He added that the pill will be available in 200 mg capsule form as a patient compliance.
Each pack will have 40 capsules as the general recommended dosage is 800 mg twice a day for 5 days, the company said.
“Going forward, the company is also working on 400 mg and 800 mg capsules. It will be available at all leading pharmacies and Covid-19 treatment centres across the country,” the statement said.
The Drug Controller General of India (DCGI) had earlier this week approved Molnupiravir for restricted use in emergency situation (EUA) in India.
Other home-grown pharma majors such as Strides Pharma, Dr Reddy’s, Sun Pharma, Cipla, Hetero, Torrent and Optimus have already announced plans to roll out their generic versions of the drug shortly.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.